By Professor Emad El-Omar

Journal articles

Furuta T; El-Omar EM; Xiao F; Shirai N; Takashima M; Sugimura H, 2002, 'Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. (vol 123, pg 92, 2002)', GASTROENTEROLOGY, 123, pp. 957 - 957

El-Omar EM; Malfertheiner P, 2001, 'Helicobacter pylori infection and gastric cancer', Current Opinion in Gastroenterology, 17, pp. S24 - S27

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer', Nature, 412, pp. 99, http://dx.doi.org/10.1038/35083631

El-Omar EM; Carrington M; Chow WH; McColl KE; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.', Nature, 412, pp. 99

El-Omar EM, 2001, 'The importance of interleukin 1 β in Helicobacter pylori associated disease', Gut, 48, pp. 743 - 747, http://dx.doi.org/10.1136/gut.48.6.743

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman A; El-Omar E; Hilditch T, 2001, 'Non-invasive HP testing versus endoscopy with HP testing for dyspepsia', GUT, 48, pp. A14 - A15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167334700053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

El-Omar EM, 2001, 'Cytokine gene polymorphisms and risk of gastric cancer', Japanese Journal of Gastroenterology, 98, pp. A303 - A305, http://dx.doi.org/10.11405/nisshoshi1964.98.87sokai_A303

El-Omar EM; Chow WH; Rabkin CS, 2001, 'Gastric cancer and H. pylori: Host genetics open the way', Gastroenterology, 121, pp. 1002 - 1004, http://dx.doi.org/10.1053/gast.2001.28739

El-Omar EM; You W-C; Chow W-H; Fraumeni JF; Rabkin CS, 2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', Gastroenterology, 120, pp. A743 - A743, http://dx.doi.org/10.1016/s0016-5085(08)83701-8

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman AW; El-Omar EM; Hilditch TE, 2001, 'Non-invasive H-pylori testing versus endoscopy with H-pylori testing for dyspepsia', GASTROENTEROLOGY, 120, pp. A238 - A238

El-Omar EM; Chow W-H; Gammon MD; Vaughan TL; Risch HA; Fraumeni JF, 2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', Gastroenterology, 120, pp. A86 - A86, http://dx.doi.org/10.1016/s0016-5085(08)80425-8

El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious - Reply', GASTROENTEROLOGY, 119, pp. 276 - 276, http://dx.doi.org/10.1016/S0016-5085(00)70071-0

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1 polymorphisms associated with increased risk of gastric cancer', Nature, 404, pp. 398 - 402, http://dx.doi.org/10.1038/35006081

McColl KEL; El-Omar E; Gillen D, 2000, 'Helicobacter pylori gastritis and gastric physiology', Gastroenterology Clinics of North America, 29, pp. 687 - 703, http://dx.doi.org/10.1016/S0889-8553(05)70138-2

ElOmar EM; Oien K; Murray LS; ElNujumi A; Wirz A; Gillen D; Williams C; Fullarton G; McColl KEL, 2000, 'Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori', Gastroenterology, 118, pp. 22 - 30, http://dx.doi.org/10.1016/S0016-5085(00)70410-0

McColl KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 2000, 'Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease', American Journal of Gastroenterology, 95, pp. 101 - 105, http://dx.doi.org/10.1016/S0002-9270(99)00765-0

McColl KEL; Gillen D; El-Omar E, 2000, 'The role of gastrin in ulcer pathogenesis', Bailliere S Best Practice and Research in Clinical Gastroenterology, 14, pp. 13 - 26, http://dx.doi.org/10.1053/bega.1999.0056

Palli D; Masala G; Russo A; Saieva C; Bazzoli F; Brenner H; Bode G; Boeing H; Parsonnet J; El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious [1] (multiple letters)', Gastroenterology, 119, pp. 274 - 276, http://dx.doi.org/10.1053/gast.2000.9116

El-Omar EM; Wang CD; McColl KE; Rabkin CS, 2000, 'Interleukin-10 promoter polymorphisms influence risk of chronic H-pylori infection.', GASTROENTEROLOGY, 118, pp. A889 - A889, http://dx.doi.org/10.1016/S0016-5085(00)85694-2

El-Omar EM; Chow WHM; McColl KE; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1β-enhancing genotypes are associated with increased risk of gastric cancer and its precursors.', GASTROENTEROLOGY, 118, pp. A181 - A181, http://dx.doi.org/10.1016/S0016-5085(00)82800-0

McColl KEL; Murray LS; El-Omar EM, 1999, 'Helicobacter pylori and nonulcer dyspepsia -: Reply', NEW ENGLAND JOURNAL OF MEDICINE, 340, pp. 1509 - 1510

Lieber CS; Puspok A; Oberhubek G; Logan RFA; Logan RPH; Ganz PA; Scott BB; McColl KEL; Murray LS; El-Omar EM; Blum AL; Talley NJ; Stolte M; Friedman LS, 1999, 'Helicobacter pylori and nonulcer dyspepsia [1] (multiple letters)', New England Journal of Medicine, 340, pp. 1508 - 1511, http://dx.doi.org/10.1056/NEJM199905133401912

Smith AD; Gillen D; Cochran KM; El-Omar E; McColl KEL, 1999, 'Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers', American Journal of Gastroenterology, 94, pp. 1209 - 1213, http://dx.doi.org/10.1016/S0002-9270(99)00124-0

Mccoll KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients: Impact of reflux disease', GUT, 44, pp. A120 - A120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079446300478&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; Murray LS; El-Omar EM, 1999, 'Reply', Gastroenterology, 117, pp. 271 - 272, http://dx.doi.org/10.1016/s0016-5085(99)70580-9

McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T, 1998, 'Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia', New England Journal of Medicine, 339, pp. 1869 - 1874, http://dx.doi.org/10.1056/NEJM199812243392601

McColl KEL; Gillen D; El-Omar E; Ardill J, 1998, 'Effect of antral atrophy on gastric function in h. pylori infection: Relevance to progression to pangastritis', Zeitschrift Fur Gastroenterologie, 36, pp. 1090

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; McColl KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GASTROENTEROLOGY, 114, pp. A590 - A590, http://dx.doi.org/10.1016/S0016-5085(98)82402-5

McColl KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ulcer ulcer dyspepsia.', GASTROENTEROLOGY, 114, pp. A222 - A222, http://dx.doi.org/10.1016/S0016-5085(98)80900-1

McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H-pylori-associated hypochlorhydria - Reply', GASTROENTEROLOGY, 114, pp. 620 - 621, http://dx.doi.org/10.1016/S0016-5085(98)70559-1

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; Mccoll KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GUT, 42, pp. A51 - A51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mccoll KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ucler dyspepsia', GUT, 42, pp. A3 - A3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; El-Nujumi A; Murray LS; El-Omar EM; Dickson A; Kelman AW; Hilditch TE, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', Gut, 42, pp. 618 - 622, http://dx.doi.org/10.1136/gut.42.5.618

Beales ILP; McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H. pylori-associated hypochlorhydria [2] (multiple letters)', Gastroenterology, 114, pp. 618 - 620, http://dx.doi.org/10.1016/s0016-5085(98)70558-x

McColl KEL; El-Omar E; Gillen D, 1998, 'Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy', British Medical Bulletin, 54, pp. 121 - 138, http://dx.doi.org/10.1093/oxfordjournals.bmb.a011663

Gillen D; El-Omar EM; Wirz AA; Ardill JES; McColl KEL, 1998, 'The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects', Gastroenterology, 114, pp. 50 - 57, http://dx.doi.org/10.1016/S0016-5085(98)70632-8

McColl KEL; EI-Nujumi A; Murray LS; El-Omar EM; Dickson A; Kelman AW; Hilditch TE, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', European Journal of Gastroenterology & Hepatology, 10, pp. 626 - 626, http://dx.doi.org/10.1097/00042737-199807000-00025

McColl KEL; El-Omar EM; Gillen D, 1997, 'Alterations in gastric physiology in Helicobacter pylori infection: Causes of different diseases or all epiphenomena?', Italian Journal of Gastroenterology and Hepatology, 29, pp. 459 - 464

McColl KEL; El-Omar E; Gillen D; Banerjee S, 1997, 'The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer', Seminars in Gastrointestinal Disease, 8, pp. 142 - 155

McColl KEL; El-Omar EM; Gillen D, 1997, 'The role of H. Pylori infection in the pathophysiology of duodenal ulcer disease', Journal of Physiology and Pharmacology, 48, pp. 287 - 295

El-Omar EM; Oien K; El-Nujumi A; Gillen D; Wirz A; Dahill S; Williams C; Ardill JES; McColl KEL, 1997, 'Helicobacter pylori infection and chronic gastric acid hyposecretion', Gastroenterology, 113, pp. 15 - 24, http://dx.doi.org/10.1016/S0016-5085(97)70075-1

Talley NJ; Agreus L; Van Zanten SV; McColl KEL; El-Omar EM; Banerjee S; Wirz A, 1997, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia (multiple letters) [1]', European Journal of Gastroenterology and Hepatology, 9, pp. 413 - 414, http://dx.doi.org/10.1097/00042737-199704000-00018

McColl KEL; El-Nujumi A; Murray L; El-Omar E; Gillen D; Dickson A; Kelman A; Hilditch TE, 1997, 'The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients', Gut, 40, pp. 302 - 306, http://dx.doi.org/10.1136/gut.40.3.302

McColl KEL; El-Omar EM; Gillen D, 1997, 'Alterations in gastric physiology in Helicobacter pylori infection: causes of different diseases or all epiphenomena? (vol 29, pg 459, 1997)', ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 631 - 631

McColl KEL; ElOmar EM; Banerjee S; Wirz A, 1997, 'Is the Glasgow Dyspepsia Severity Score a useful tool for the measurement of dyspepsia? Reply', EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 9, pp. 413 - 414, http://dx.doi.org/10.1097/00042737-199704000-00019

El-Omar E; Banerjee S; Wirz A; Penman I; Ardill JES; McColl KEL, 1996, 'Marked rebound acid hypersecretion after treatment with ranitidine', American Journal of Gastroenterology, 91, pp. 355 - 359

Graham DY; El-Omar E; Gillen G; McColl KEL, 1996, 'Gastrin-releasing peptide, acid secretion, Helicobacter pylori, and duodenal ulcer: Another epiphenomenon? [4]', Gastroenterology, 110, pp. 1325 - 1326, http://dx.doi.org/10.1053/gast.1996.v110.agast961325

Banerjee S; El-Omar E; Mowat A; Ardill JES; Park RHR; Watson W; Beattie AD; McColl KEL, 1996, 'Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer', Gastroenterology, 110, pp. 717 - 724, http://dx.doi.org/10.1053/gast.1996.v110.pm8608880

El-Omar EM; Banerjee S; Wirz A; McColl KEL, 1996, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia', European Journal of Gastroenterology and Hepatology, 8, pp. 967 - 971, http://dx.doi.org/10.1097/00042737-199610000-00006

El-Omar E; Penman I; Ardill JES; McColl KEL, 1995, 'A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients', Gut, 36, pp. 534 - 538, http://dx.doi.org/10.1136/gut.36.4.534

Back to profile page